MedTrace Logo

Hyperglycemic Profiles in Obstructive Sleep Apnea: Effects of PAP Therapy

NCT02454153 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2021-05-25

Study results available
· View outcomes & findings →

Summary

This is a randomized control trial in people with diabetes and obstructive sleep apnea who will be randomly assigned for 3 months to PAP therapy along with healthy lifestyle and sleep education or healthy lifestyle and sleep education.

Conditions

Interventions

DEVICE

REMStar Positive Airway Pressure

Positive airway pressure therapy is the standard of care for managing obstructive sleep apnea

BEHAVIORAL

LifeStyle Counseling

Lifestyle guidelines developed by the American Diabetes Association for weight loss will be provided to all subjects.

Sponsors & Collaborators

Principal Investigators

  • Naresh M Punjabi, MD, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2020-03-15
Completion
2020-03-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02454153 on ClinicalTrials.gov